This list is an analysis based on recent market events. It's not an investment recommendation.
About
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
The current price of GELS is $0.49 USD — it has decreased by -3.14% in the past 24 hours. Watch Gelteq stock price performance more closely on the chart.
What is Gelteq stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Gelteq stocks are traded under the ticker GELS.
Is Gelteq stock price growing?▼
GELS stock has risen by +13.98% compared to the previous week, the month change is a -9.74% fall, over the last year Gelteq has showed a -58.47% decrease.
What is Gelteq market cap?▼
Today Gelteq has the market capitalization of 5.25M
What is Gelteq revenue for the last year?▼
Gelteq revenue for the last year amounts to 109,173.22 USD.
What is Gelteq net income for the last year?▼
GELS net income for the last year is -4.24M USD.
How many employees does Gelteq have?▼
As of November 1, 2026, the company has 8 employees.